Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2021-02-04 Sale | 2021-02-05 4:36 pm | Epizyme Inc. | EPZM | Ros Matthew See Remarks | 894 | $11.21 | $10,022 | 83,188 (Direct) | View |
2021-01-25 Sale | 2021-01-27 8:42 pm | Epizyme Inc. | EPZM | Ros Matthew See Remarks | 2,872 | $11.41 | $32,770 | 55,957 (Direct) | View |
2020-06-26 Sale | 2020-06-30 08:54 am | Epizyme Inc. | EPZM | Ros Matthew See Remarks | 2,728 | $16.15 | $44,057 | 57,507 (Direct) | View |
2020-06-18 Sale | 2020-06-22 7:31 pm | Epizyme Inc. | EPZM | Ros Matthew See Remarks | 112,003 | $21.24 | $2,378,444 | 374,719 (Direct) | View |
2020-03-25 Sale | 2020-03-26 9:01 pm | Epizyme Inc. | EPZM | Ros Matthew See Remarks | 1,243 | $15.28 | $18,993 | 51,798 (Direct) | View |
2020-01-24 Sale | 2020-01-27 9:18 pm | Epizyme Inc. | EPZM | Ros Matthew See Remarks | 1,847 | $24.64 | $45,510 | 39,790 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-06-05 Option Award | 2024-06-13 7:14 pm | N/A 2034-06-05 | Cogent Biosciences Inc. | COGT | Ros Matthew Director | 44,700 | $0 | 44,700 (Direct) | View |
2024-01-02 Option Award | 2024-01-04 4:20 pm | 2024-01-02 2034-01-02 | Cogent Biosciences Inc. | COGT | Ros Matthew Director | 3,051 | $0 | 3,051 (Direct) | View |
2023-10-02 Option Award | 2023-10-03 4:56 pm | 2023-10-02 2033-10-02 | Cogent Biosciences Inc. | COGT | Ros Matthew Director | 2,170 | $0 | 2,170 (Direct) | View |
2023-07-03 Option Award | 2023-07-05 4:53 pm | 2023-07-03 2033-07-03 | Cogent Biosciences Inc. | COGT | Ros Matthew Director | 1,743 | $0 | 1,743 (Direct) | View |
2023-06-07 Option Award | 2023-06-08 4:41 pm | N/A 2033-06-07 | Cogent Biosciences Inc. | COGT | Ros Matthew Director | 36,700 | $0 | 36,700 (Direct) | View |
2023-04-03 Option Award | 2023-04-04 4:15 pm | 2023-04-03 2033-04-03 | Cogent Biosciences Inc. | COGT | Ros Matthew Director | 1,900 | $0 | 1,900 (Direct) | View |
2023-01-03 Option Award | 2023-01-04 4:31 pm | 2023-01-03 2033-01-03 | Cogent Biosciences Inc. | COGT | Ros Matthew Director | 1,792 | $7.1854 | 1,792 (Direct) | View |
2022-10-03 Option Award | 2022-10-04 4:35 pm | 2022-10-03 2032-10-03 | Cogent Biosciences Inc. | COGT | Ros Matthew Director | 1,419 | $9.076 | 1,419 (Direct) | View |
2022-07-01 Option Award | 2022-07-05 1:51 pm | 2022-07-01 2032-07-01 | Cogent Biosciences Inc. | COGT | Ros Matthew Director | 2,194 | $5.8706 | 2,194 (Direct) | View |
2022-06-07 Option Award | 2022-06-09 5:09 pm | N/A 2032-06-07 | Cogent Biosciences Inc. | COGT | Ros Matthew Director | 30,700 | $0 | 30,700 (Direct) | View |
2022-04-01 Option Award | 2022-04-05 4:05 pm | 2022-04-01 2032-04-01 | Cogent Biosciences Inc. | COGT | Ros Matthew Director | 2,650 | $4.86 | 2,650 (Direct) | View |
2022-01-03 Option Award | 2022-01-04 9:24 pm | N/A 2032-01-03 | Cogent Biosciences Inc. | COGT | Ros Matthew Director | 2,256 | $5.153 | 2,256 (Direct) | View |
2021-10-01 Option Award | 2021-10-05 7:11 pm | N/A 2031-10-01 | Cogent Biosciences Inc. | COGT | Ros Matthew Director | 2,463 | $5.0317 | 2,463 (Direct) | View |
2021-08-16 Option Award | 2021-08-18 08:02 am | N/A 2031-08-15 | Epizyme Inc. | EPZM | Ros Matthew See Remarks | 162,303 | $0 | 245,491 (Direct) | View |
2021-07-01 Option Award | 2021-07-06 7:08 pm | N/A 2031-07-01 | Cogent Biosciences Inc. | COGT | Ros Matthew Director | 2,225 | $4.7754 | 2,225 (Direct) | View |
2021-04-01 Option Award | 2021-04-05 9:06 pm | N/A 2031-04-01 | Cogent Biosciences Inc. | COGT | Ros Matthew Director | 2,068 | $5.6557 | 2,068 (Direct) | View |
2021-03-11 Option Award | 2021-03-15 7:00 pm | N/A 2031-03-11 | Cogent Biosciences Inc. | COGT | Ros Matthew Director | 60,000 | $0 | 60,000 (Direct) | View |
2021-02-01 Option Award | 2021-02-02 9:05 pm | N/A 2031-01-31 | Epizyme Inc. | EPZM | Ros Matthew See Remarks | 162,303 | $0 | 218,260 (Direct) | View |
2021-01-04 Option Award | 2021-01-06 9:48 pm | N/A 2031-01-04 | Cogent Biosciences Inc. | COGT | Ros Matthew Director | 1,641 | $0 | 1,641 (Direct) | View |
2020-10-01 Option Award | 2020-10-02 5:30 pm | N/A 2030-10-01 | Unum Therapeutics Inc. | UMRX | Ros Matthew Director | 9,247 | $1.3518 | 9,247 (Direct) | View |
2020-07-01 Option Award | 2020-07-06 4:27 pm | N/A 2030-07-01 | Unum Therapeutics Inc. | UMRX | Ros Matthew Director | 35,280 | $0.3118 | 35,280 (Direct) | View |
2020-06-25 Option Award | 2020-06-30 08:54 am | N/A N/A | Epizyme Inc. | EPZM | Ros Matthew See Remarks | 6,000 | $0 | 57,507 (Direct) | View |
2020-03-24 Option Award(A) | 2020-06-30 06:10 am | N/A N/A | Epizyme Inc. | EPZM | Ros Matthew See Remarks | 4,000 | $0 | 54,235 (Direct) | View |
2020-06-18 Exercise | 2020-06-22 7:31 pm | N/A 2029-01-23 | Epizyme Inc. | EPZM | Ros Matthew See Remarks | 112,003 | $0 | 374,719 (Direct) | View |
2020-06-18 Exercise | 2020-06-22 7:31 pm | N/A N/A | Epizyme Inc. | EPZM | Ros Matthew See Remarks | 41,063 | $9.12 | 374,719 (Direct) | View |
2020-06-18 Exercise | 2020-06-22 7:31 pm | N/A N/A | Epizyme Inc. | EPZM | Ros Matthew See Remarks | 68,651 | $9.58 | 374,719 (Direct) | View |
2020-06-18 Exercise | 2020-06-22 7:31 pm | N/A N/A | Epizyme Inc. | EPZM | Ros Matthew See Remarks | 2,289 | $12.45 | 374,719 (Direct) | View |
2020-06-09 Option Award | 2020-06-11 4:25 pm | N/A 2030-06-09 | Unum Therapeutics Inc. | UMRX | Ros Matthew Director | 14,331 | $0 | 14,331 (Direct) | View |
2020-04-06 Option Award | 2020-04-08 5:41 pm | N/A 2030-04-06 | Unum Therapeutics Inc. | UMRX | Ros Matthew Director | 49,887 | $0.2205 | 49,887 (Direct) | View |
2020-03-24 Option Award | 2020-03-26 9:01 pm | N/A N/A | Epizyme Inc. | EPZM | Ros Matthew See Remarks | 1,563 | $0 | 51,798 (Direct) | View |
2020-02-03 Option Award | 2020-02-05 6:03 pm | N/A 2030-02-02 | Epizyme Inc. | EPZM | Ros Matthew See Remarks | 67,901 | $0 | 107,691 (Direct) | View |
2020-01-24 Tax Withholding | 2020-01-27 9:18 pm | N/A N/A | Epizyme Inc. | EPZM | Ros Matthew See Remarks | 2,395 | $22.4 | 39,790 (Direct) | View |
2020-01-23 Option Award | 2020-01-27 9:18 pm | N/A N/A | Epizyme Inc. | EPZM | Ros Matthew See Remarks | 5,000 | $0 | 39,790 (Direct) | View |
2020-01-02 Option Award | 2020-01-06 4:45 pm | N/A 2030-01-02 | Unum Therapeutics Inc. | UMRX | Ros Matthew Director | 24,274 | $0.4532 | 24,274 (Direct) | View |